Search Results - "Mangasarova, Yana"
-
1
The HSP Immune Network in Cancer
Published in Frontiers in immunology (30-11-2021)“…Heat shock proteins are molecular chaperones which support tumor development by regulating various cellular processes including unfolded protein response,…”
Get full text
Journal Article -
2
HSP70 and HSP90 in Cancer: Cytosolic, Endoplasmic Reticulum and Mitochondrial Chaperones of Tumorigenesis
Published in Frontiers in oncology (21-01-2022)“…HSP70 and HSP90 are two powerful chaperone machineries involved in survival and proliferation of tumor cells. Residing in various cellular compartments, HSP70…”
Get full text
Journal Article -
3
Heat Shock Proteins in Lymphoma Immunotherapy
Published in Frontiers in immunology (18-03-2021)“…Immunotherapy harnessing the host immune system for tumor destruction revolutionized oncology research and advanced treatment strategies for lymphoma patients…”
Get full text
Journal Article -
4
Corrigendum: HSP70 and HSP90 in cancer: cytosolic, endoplasmic reticulum and mitochondrial chaperones of tumorigenesis
Published in Frontiers in oncology (03-05-2023)“…[This corrects the article DOI: 10.3389/fonc.2022.829520.]…”
Get full text
Journal Article -
5
Impaired Heat Shock Protein Expression in Activated T Cells in B-Cell Lymphoma
Published in Biomedicines (28-10-2022)“…Heat shock proteins (HSPs) are molecular chaperones that act in a variety of cellular processes, ensuring protein homeostasis and integrity. HSPs play critical…”
Get full text
Journal Article -
6
Aberrant HSP90 Expression in Lymphocytes and HSP90 Response to Anti-PD-1 Therapy in Lymphoma Patients
Published in Frontiers in immunology (28-04-2022)“…HSP90 family of molecular chaperones has been shown to be implicated in various stages of tumor growth and development. Recent studies have highlighted the…”
Get full text
Journal Article -
7
Heat Shock Proteins in Urine as Cancer Biomarkers
Published in Frontiers in medicine (08-10-2021)“…Heat shock proteins (HSPs) are a large family of molecular chaperones, which have shown to be implicated in various hallmarks of cancer such as resistance to…”
Get full text
Journal Article -
8
STR Profiling Reveals Tumor Genome Instability in Primary Mediastinal B-Cell Lymphoma
Published in Current oncology (Toronto) (10-05-2022)“…Primary mediastinal B-cell lymphoma (PMBCL) is the only non-Hodgkin's lymphoma variant responding to immune checkpoint inhibitor (ICI) therapy, approximately…”
Get full text
Journal Article -
9
PB2344: STR‐LOCI ALLELE IMBALANCE AT 9P24.1 AND PD‐L1 EXPRESSION IN PRIMARY MEDIASTINAL B‐CELL LYMPHOMA
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
10
Treatment Patterns and Their Results Among a Cohort of Patients With T-Cell Lymphomas in the Russian Federation
Published in Clinical lymphoma, myeloma and leukemia (01-09-2024)Get full text
Journal Article -
11
TCL-484 Treatment Patterns and Their Results Among a Cohort of Patients With T-Cell Lymphomas in the Russian Federation
Published in Clinical lymphoma, myeloma and leukemia (01-09-2024)“…Peripheral T-cell lymphomas (PTCLs) are a rare group of aggressive lymphoproliferative diseases with unfavorable prognosis. Using personalized approaches,…”
Get full text
Journal Article -
12
Transformed and De Novo Variants of Follicular Lymphoma: Analysis of Patient Survival Based on Modern Therapy Protocols
Published in Clinical lymphoma, myeloma and leukemia (01-09-2024)Get full text
Journal Article -
13
IBCL-548 Transformed and De Novo Variants of Follicular Lymphoma: Analysis of Patient Survival Based on Modern Therapy Protocols
Published in Clinical lymphoma, myeloma and leukemia (01-09-2024)“…Transformed cases of follicular lymphoma (FL) are accompanied by an increased risk of therapy resistance, low overall survival (OS), and low event-free…”
Get full text
Journal Article -
14
IBCL-554 Outcomes of BCL2-R+ and BCL2-RFollicular Lymphoma Treatment
Published in Clinical lymphoma, myeloma and leukemia (01-09-2024)“…About 80% of patients with FL have an indolent course of the disease, but 55% with an indolent course after first-line therapy has early relapse/progression…”
Get full text
Journal Article -
15
Outcomes of BCL2-R+ and BCL2-R- Follicular Lymphoma Treatment
Published in Clinical lymphoma, myeloma and leukemia (01-09-2024)Get full text
Journal Article -
16
TCL-177 Study of PD1 and PDL1 Expression in Cutaneous T-Cell Lymphomas
Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)“…It is known that one of the most difficult issues is the differential diagnosis of cutaneous T-cell lymphomas both within the group itself and with other…”
Get full text
Journal Article -
17
POSTER: TCL-177 Study of PD1 and PDL1 Expression in Cutaneous T-Cell Lymphomas
Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)Get full text
Journal Article -
18
ABCL-285 Aggressive Lymphomas in Pregnancy
Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)“…A diagnosis of cancer as a complication of pregnancy, is an uncommon occurrence, with an incidence of approximately 1 in 1000. Lymphoma is the fourth most…”
Get full text
Journal Article -
19
POSTER: ABCL-285 Aggressive Lymphomas in Pregnancy
Published in Clinical lymphoma, myeloma and leukemia (01-09-2023)Get full text
Journal Article -
20
ABCL-482 Primary Mediastinal B-Cell Lymphoma During Pregnancy
Published in Clinical lymphoma, myeloma and leukemia (01-09-2024)“…Primary mediastinal B-cell lymphoma (PMBCL) during pregnancy is rare, with limited data on how pregnancy impacts disease outcomes. To evaluate the outcomes of…”
Get full text
Journal Article